GCP Clinplus key facts
- Opeartor of a contract research organization catering to the clinical development of innovative pharmaceuticals and medical devices.
- It has raised $14.9M; the latest was Later Stage VC in Aug 2025.
- Notable investors include Taikun Fund, Bioinsight Ventures, Guanyou Development Investment, Hangzhou Tigermed Consulting Company, Lula Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·Watch GCP Clinplus: the Monday email on marks, rounds and moves
GCP Clinplus funding rounds
No funding rounds for GCP Clinplus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
GCP Clinplus investors
6 investors are on record for GCP Clinplus, including Taikun Fund, Bioinsight Ventures, Guanyou Development Investment and Hangzhou Tigermed Consulting Company.
About GCP Clinplus
Opeartor of a contract research organization catering to the clinical development of innovative pharmaceuticals and medical devices. The company's offerings feature full-service clinical research solutions for drugs, biopharmaceuticals, vaccines, cell and gene therapies, medical devices, traditional Chinese medicine, and natural medicines.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2010
- Employees
- 500
- Website
- gcp-clinplus.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
GCP Clinplus doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.